Litcius/Paper detail

Cabozantinib in patients with advanced Ewing sarcoma or osteosarcoma (CABONE): a multicentre, single-arm, phase 2 trial

Antoîne Italiano, Olivier Mir, Simone Mathoulin‐Pélissier, Nicolas Penel, Sophie Piperno‐Neumann, Emmanuelle Bompas, Christine Chevreau, Florence Duffaud, Natacha Entz‐Werlé, Esma Saâda, I. L. Ray-Coquard, Cyril Lervat, Nathalie Gaspar, Perrine Marec‐Bérard, Hélène Pacquement, John Wright, Maud Toulmonde, Alban Bessede, Amandine Crombé, Michèle Kind, Carine Bellera, Jean-Yves Blay

2020The Lancet Oncology322 citationsDOIOpen Access PDF

Topics & Concepts

MedicineCabozantinibSarcomaOsteosarcomaClinical endpointInternal medicineOncologyPopulationPazopanibEwing's sarcomaSurgeryClinical trialCancerPathologyEnvironmental healthSunitinibSarcoma Diagnosis and TreatmentBone Tumor Diagnosis and TreatmentsAngiogenesis and VEGF in Cancer